HEALTHCRM · Reference Measurements and health reference materials for adverse reaction-type analytes
6РП — Действия „Мария Кюри“
- Период
- 2007-03-03 → 2009-03-02
- Финансиране от ЕС
- 25 364 €
- Участници
- 1
- Схема
- EIF
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Стандартни еталонни материали за биомолекулярни маркери и алергени, като тези при целиакната болест, се разработват за прецизни измервания. Те осигуряват точност при диагностиката и контрол на качеството, което помага за вземането на правилни решения в здравеопазването.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
The research project is aimed at the development and production of reference systems including reference materials in the field of health. Two major areas will be addressed: At first, adverse reactions and establishment of consistent approaches for CRMs which are commutable and may serve both, the purposes of food industry for necessary screening and clinical or bioassays used in the context of in vitro diagnostics. The project will be aligned with the activities of IRMM in the field on coeliac disease, and on other adverse reaction-type diseases. Secondly, biomolecular markers will be in the focus on the basis of the co-operation with IFCC. This includes qualitative and quantitative standards for specific protein patterns with immunological relevance in the field of health. Validation, standardization, internal and external quality control of tests and methods are particularly relevant, when the results are utilized in decision making processes in healthcare, or in any decisions of major professional or financial impact. As patterns of bioactive proteins are becoming major targets for clinical laboratory analysis, benchmark reagents will play an increasingly important role in standardization. Availability of reliable national and international standards will promote automation and improve third party reimbursement for clinical testing. Furthermore, Production of standards will provide appropriate materials for quality assurance and quality control (QA/QC), and proficiency testing in the area of biomolecular testing. Production of CRMs will serve the diagnostic and biotechnology community, and help manufacturers benchmark a variety of their testing platforms. In a global economy measurement results serve as the international language of commerce and trade as well as consumer protection.
Оригинален текст от CORDIS (на английски).
Участници
- EUROPEAN COMMISSION-JOINT RESEARCH CENTRE · BRUSSELSКоординаторНиво градБелгия
Връзки
Данни: CORDIS, © Европейски съюз